Tomokazu Kawaoka

15PUBLICATIONS
32CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursRadiation therapyMedical biochemistry - lipidsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Mar 31, 2026
Multidisciplinary Treatment With Hepatic Arterial Infusion Chemotherapy, Radiotherapy, and Immunotherapy for Advanced Hepatocellular Carcinoma With Major Vascular Invasion: Prospective Registry Protocol.

Yoshiko Doi, Hiroshi Aikata, Yumi Kosaka

|Feb 07, 2026
Efficacy and Safety of Second-Line Lenvatinib After First-Line Durvalumab Plus Tremelimumab in Unresectable Hepatocellular Carcinoma.

Ryoichi Miura, Tomokazu Kawaoka, Saki Sueda

|Oct 24, 2024
A case of complete response to radiotherapy combined with durvalumab and tremelimumab in a patient with unknown primary hepatocellular carcinoma arising in the lumbar spine.

Aiko Tanaka, Tomokazu Kawaoka, Shinsuke Uchikawa

|May 28, 2024
Influence of dispersion slope on the diagnosis of liver fibrosis by the shear wave in metabolic dysfunction-associated steatotic liver disease.

Naoyuki Ueda, Sho Mokuda, Tomokazu Kawaoka

|Mar 13, 2024
Efficacy and safety of atezolizumab plus bevacizumab in patients with portal hypertension for unresectable hepatocellular carcinoma.

Takahiro Kinami, Shinsuke Uchikawa, Tomokazu Kawaoka

|Mar 23, 2023
Impact of skeletal muscle volume on patients with BCLC stage-B hepatocellular carcinoma undergoing sorafenib therapy.

Issei Saeki, Takahiro Yamasaki, Yurika Yamauchi

Pageof 3

Frequent Collaborators

4 joint publications

Shinsuke Uchikawa

4 joint publications

Hiroshi Aikata

2 joint publications

Shiro Oka

2 joint publications

Kazuaki Chayama